Literature DB >> 23172408

Validation of the ICF core set for neuromuscular diseases.

I Bos1, H A Stallinga, B Middel, J B M Kuks, K Wynia.   

Abstract

BACKGROUND: Understanding of the consequences of a neuromuscular disease (NMD) can improve when a valid sample of disease-specific categories based on the International Classification of Functioning, Disabilities, and Health (ICF) is available.
OBJECTIVE: To examine the content validity of the initial ICF Core Set for neuromuscular diseases (NMDs). The initial ICF Core Set was developed for three chronic neurological diseases.
DESIGN: A qualitative method.
METHODS: To examine the content validity of the initial ICF Core Set for NMD, concepts in established disease-specific health-related Quality of Life Questionnaires (HRQOL) were compared with ICF categories. Next, the selected ICF categories were linked to the ICF categories in the initial ICF Core Set.
RESULTS: All concepts in the HRQOL questionnaires, except one body function concept, were covered by the initial ICF Core Set. However, the NMD Core Set reflects a broader scope concerning health problems than the concepts in the HRQOL questionnaires do, especially concerning the "Participation" and "Environmental Factors" components.
CONCLUSION: The NMD Core Set, as well as a measurement based on this Core Set, can contribute to a better understanding of the consequences of NMDs and can also serve as a basis for clinical practice, research, social security systems, and educational programs. CLINICAL REHABILITATION IMPACT: The newly developed NMD Core Set can be a basis for enhancing the development of rehabilitation interventions and improving overall health care for patients with a NMD.

Entities:  

Mesh:

Year:  2012        PMID: 23172408

Source DB:  PubMed          Journal:  Eur J Phys Rehabil Med        ISSN: 1973-9087            Impact factor:   2.874


  5 in total

1.  Construction of a Quality of Life Questionnaire for slowly progressive neuromuscular disease.

Authors:  Antoine Dany; Coralie Barbe; Amandine Rapin; Christian Réveillère; Jean-Benoit Hardouin; Isabella Morrone; Aurore Wolak-Thierry; Moustapha Dramé; Arnaud Calmus; Sabrina Sacconi; Guillaume Bassez; Vincent Tiffreau; Isabelle Richard; Benjamin Gallais; Hélène Prigent; Redha Taiar; Damien Jolly; Jean-Luc Novella; François Constant Boyer
Journal:  Qual Life Res       Date:  2015-07-04       Impact factor: 4.147

2.  Application of the International Classification of Functioning, Disability and Health system to symptoms of the Duchenne and Becker muscular dystrophies.

Authors:  Kristin M Conway; Emma Ciafaloni; Dennis Matthews; Chris Westfield; Kathy James; Pangaja Paramsothy; Paul A Romitti
Journal:  Disabil Rehabil       Date:  2017-04-11       Impact factor: 3.033

3.  Stability and relative validity of the Neuromuscular Disease Impact Profile (NMDIP).

Authors:  Isaäc Bos; Jan B M Kuks; Josué Almansa; Hubertus P H Kremer; Klaske Wynia
Journal:  BMC Neurol       Date:  2017-05-11       Impact factor: 2.474

Review 4.  20 Years of ICF-International Classification of Functioning, Disability and Health: Uses and Applications around the World.

Authors:  Matilde Leonardi; Haejung Lee; Nenad Kostanjsek; Arianna Fornari; Alberto Raggi; Andrea Martinuzzi; Manuel Yáñez; Ann-Helene Almborg; Magdalena Fresk; Yanina Besstrashnova; Alexander Shoshmin; Shamyr Sulyvan Castro; Eduardo Santana Cordeiro; Marie Cuenot; Christine Haas; Soraya Maart; Thomas Maribo; Janice Miller; Masahiko Mukaino; Stefanus Snyman; Ulrike Trinks; Heidi Anttila; Jaana Paltamaa; Patricia Saleeby; Lucilla Frattura; Ros Madden; Catherine Sykes; Coen H van Gool; Jakub Hrkal; Miroslav Zvolský; Petra Sládková; Marie Vikdal; Guðrún Auður Harðardóttir; Josephine Foubert; Robert Jakob; Michaela Coenen; Olaf Kraus de Camargo
Journal:  Int J Environ Res Public Health       Date:  2022-09-08       Impact factor: 4.614

5.  Management of motor rehabilitation in individuals with muscular dystrophies. 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019).

Authors:  Maria Elena Lombardo; Elena Carraro; Cristina Sancricca; Michela Armando; Michela Catteruccia; Elena Mazzone; Giulia Ricci; Ferdinando Salamino; Filippo Maria Santorelli; Massimiliano Filosto
Journal:  Acta Myol       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.